Brief: Alligator Bioscience Carries Out A 100% Secured Rights Issue Of About SEK 257 Million

Alligator Bioscience AB

07/10/2021 07:15

Oct 7 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * ALLIGATOR CARRIES OUT A 100 PERCENT SECURED RIGHTS ISSUE
OF
APPROXIMATELY SEK 257 MILLION
    * ALLIGATOR WILL USE PROCEEDS FROM RIGHTS ISSUE TO CONDUCT
PHASE
II STUDIES FOR MITAZALIMAB, PREPARATIONS FOR AND INITIATION OF
PHASE II STUDIES FOR ATOR-1017 AND FURTHER DEVELOPMENT OF OTHER
PIPELINE CANDIDATES.
    * ONE (1) EXISTING SHARE IN COMPANY ENTITLES TO THREE (3)
SUBSCRIPTION RIGHTS
    * TWO (2) SUBSCRIPTION RIGHTS ENTITLE TO SUBSCRIPTION OF ONE
(1)
NEW SHARE, I.E., A SUBSCRIPTION RATIO OF 3:2
    * SUBSCRIPTION PRICE IS SEK 2 PER NEW SHARE
    * ASSUMING RIGHTS ISSUE IS FULLY SUBSCRIBED, RESULTS IN
COMPANY
RECEIVING ISSUE PROCEEDS OF APPROXIMATELY SEK 257 MLN BEFORE
DEDUCTION OF TRANSACTION COSTS
    * SUBSCRIPTION PERIOD RUNS FROM AND INCLUDING 12 NOVEMBER
2021 UP
TO AND INCLUDING 26 NOVEMBER 2021

Source text for Eikon:  ID:nWkr8fCf02 
Further company coverage:  ATORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))